Novonesis (Novozymes) B (fra:NZM2) Share Price

Company Profile

Business description
Novonesis was formed in 2024 through the merger of Novozymes and Chr. Hansen. Following the merger, the company became the world leader in industrial enzymes and microbial solutions, with a nearly 50% market share in both. The firm supplies a wide range of industry groups: household care, food and beverages, bioenergy, agriculture and feed, technical and pharmaceuticals. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark, employs around 10,000 people, and works across more than 30 research and development and application centers and 23 manufacturing sites.
Contact
Krogshoejvej 36
Bagsvaerd2880
DNK
T: +45 44460000
https://www.novozymes.com
Sector
Basic Materials
Stock type
Cyclical
Industry
Specialty Chemicals
Fiscal Year End
31 December 2025
Employees
6,756

Recommended

The market is underestimating the clear path to profitability.

Roy van Keulen | 14 January 2025

Shares drop 17% after guidance is revised but we still see value.

Shane Ponraj | 09 January 2025

Australia's premier gas infrastructure firm used to be a market darling, but its shares have taken a severe de-rating in recent years.

Joseph Taylor | 09 January 2025

Index	Last price	Change	% Change
All Ordinaries	8,456.80	15.00	-0.18%
CAC 40	7,423.67	15.03	0.20%
DAX 40	20,271.33	138.48	0.69%
Dow JONES (US)	42,518.28	221.16	0.52%
FTSE 100	8,201.54	22.65	-0.28%
HKSE	19,238.39	18.61	0.10%
NASDAQ	19,044.39	43.71	-0.23%
Nikkei 225	38,384.61	89.69	-0.23%
NZX 50 Index	12,943.57	59.19	0.46%
S&P 500	5,842.91	6.69	0.11%
S&P/ASX 200	8,213.30	17.70	-0.22%
SSE Composite Index	3,228.61	12.33	-0.38%